Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Elizabeth A. Fry & Kazushi Inoue. (2019) c-MYB and DMTF1 in Cancer. Cancer Investigation 37:1, pages 46-65.
Read now
Read now
Elda Tagliabue, Andrea Balsari, Manuela Campiglio & Serenella M Pupa. (2010) HER2 as a target for breast cancer therapy. Expert Opinion on Biological Therapy 10:5, pages 711-724.
Read now
Read now
Pankaj Taneja, Donna P Frazier, Robert D Kendig, Dejan Maglic, Takayuki Sugiyama, Fumitake Kai, Neetu K Taneja & Kazushi Inoue. (2009) MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Review of Molecular Diagnostics 9:5, pages 423-440.
Read now
Read now
Articles from other publishers (78)
Prabin Dhangada Majhi, Aman Sharma & D. Joseph Jerry. (2023) Genetic modifiers of p53: opportunities for breast cancer therapies. Oncotarget 14:1, pages 236-241.
Crossref
Crossref
Ashly Hindle, Chhanda Bose, Jihyun Lee, Philip T. Palade, Christopher J. Peterson, P. Hemachandra Reddy, Sanjay Awasthi & Sharda P. Singh. (2022) Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels. Cancers 14:3, pages 527.
Crossref
Crossref
Tinslee Dilday & Elizabeth Yeh. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
11
34
.
Christian Bassi, Jerome Fortin, Bryan E. Snow, Andrew Wakeham, Jason Ho, Jillian Haight, Annick You-Ten, Emily Cianci, Luke Buckler, Chiara Gorrini, Vuk Stambolic & Tak W. Mak. (2021) The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer. Cell Death & Differentiation 28:11, pages 3036-3051.
Crossref
Crossref
Prabin Dhangada Majhi, Nicholas B. Griner, Jacob A. Mayfield, Shannon Compton, Jeffrey J. Kane, Trevor A. Baptiste, Karen A. Dunphy, Amy L. Roberts, Sallie S. Schneider, Evan M. Savage, Divyen Patel, Anneke C. Blackburn, Kim Joana Maurus, Lisa Wiesmüller & D. Joseph Jerry. (2021) Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome. Oncogene 40:31, pages 5026-5037.
Crossref
Crossref
Sharda P. Singh, Jihyun Lee, Chhanda Bose, Hongzhi Li, Yate-Ching Yuan, Ashly Hindle, Sharad S. Singhal, Jonathan Kopel, Philip T. Palade, Catherine Jones, Rakhshanda L. Rahman & Sanjay Awasthi. (2021) Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis. Cancers 13:13, pages 3329.
Crossref
Crossref
Chong Liu, Pei Wu, Ailin Zhang & Xiaoyun Mao. (2021) Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing. Frontiers in Oncology 11.
Crossref
Crossref
Xiang Zhou, Qian Hao & Hua Lu. (2019) Mutant p53 in cancer therapy—the barrier or the path. Journal of Molecular Cell Biology 11:4, pages 293-305.
Crossref
Crossref
Nishant Gandhi & Gokul Das. (2019) Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications. Cells 8:2, pages 89.
Crossref
Crossref
Elizabeth A. Fry, Pankaj Taneja & Kazushi Inoue. (2017) Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu. International Journal of Cancer 140:3, pages 495-503.
Crossref
Crossref
Alisha R. Yallowitz, Dun Li, Anthony Lobko, Daniel Mott, Alice Nemajerova & Natalia Marchenko. (2015) Mutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis. Molecular Cancer Research 13:4, pages 743-754.
Crossref
Crossref
Heather L. LehmanDouglas B. Stairs. (2015) Single and Multiple Gene Manipulations in Mouse Models of Human Cancer. Cancer Growth and Metastasis 8s1, pages CGM.S21217.
Crossref
Crossref
Yihua Wang & Xin Lu. 2015. Cell Polarity 2. Cell Polarity 2
167
186
.
Tao Deng, Jeff C. Liu, Philip E.D. Chung, David Uehling, Ahmed Aman, Babu Joseph, Troy Ketela, Zhe Jiang, Nathan F. Schachter, Robert Rottapel, Sean E. Egan, Rima Al-awar, Jason Moffat & Eldad Zacksenhaus. (2014) shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer. Cancer Research 74:7, pages 2119-2130.
Crossref
Crossref
J L Little, V Serzhanova, E Izumchenko, B L Egleston, E Parise, A J Klein-Szanto, G Loudon, M Shubina, S Seo, M Kurokawa, M F Ochs & E A Golemis. (2013) A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice. Oncogene 33:4, pages 411-420.
Crossref
Crossref
Pavla Brachova, Samuel R. Mueting, Eric J. Devor & Kimberly K. Leslie. (2014) Oncomorphic <i>TP</i>53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex. Journal of Cancer Therapy 05:06, pages 506-516.
Crossref
Crossref
D Maglic, S Zhu, E A Fry, P Taneja, F Kai, R D Kendig, T Sugiyama, L D Miller, M C Willingham & K Inoue. (2012) Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer. Oncogene 32:35, pages 4120-4129.
Crossref
Crossref
Rafaela Andrade-Vieira, Zhaolin Xu, Patricia Colp & Paola A. Marignani. (2013) Loss of lkb1 Expression Reduces the Latency of ErbB2-Mediated Mammary Gland Tumorigenesis, Promoting Changes in Metabolic Pathways. PLoS ONE 8:2, pages e56567.
Crossref
Crossref
Anni Laine, Harri Sihto, Christophe Come, Mathias T. Rosenfeldt, Aleksandra Zwolinska, Minna Niemelä, Anchit Khanna, Edward K. Chan, Veli-Matti Kähäri, Pirkko-Liisa Kellokumpu-Lehtinen, Owen J. Sansom, Gerard I. Evan, Melissa R. Junttila, Kevin M. Ryan, Jean-Christophe Marine, Heikki Joensuu & Jukka Westermarck. (2013) Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1. Cancer Discovery 3:2, pages 182-197.
Crossref
Crossref
Katerina I. LeonovaLeonid BrodskyBrittany LipchickMahadeb PalLiliya NovototskayaAlex A. ChenchikGanes C. Sen, Elena A. KomarovaAndrei V. Gudkov. (2012) p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proceedings of the National Academy of Sciences 110:1.
Crossref
Crossref
Wolfgang Deppert & Genrich Tolstonog. 2013. p53 in the Clinics. p53 in the Clinics
109
126
.
Igor E. Koman, Mairead Commane, Geraldine Paszkiewicz, Bhupinder Hoonjan, Srabani Pal, Alfiya Safina, Ilya Toshkov, Andrei A. Purmal, Dan Wang, Song Liu, Carl Morrison, Andrei V. Gudkov & Katerina V. Gurova. (2012)
Targeting FACT Complex Suppresses Mammary Tumorigenesis in
Her2
/
neu
Transgenic Mice
. Cancer Prevention Research 5:8, pages 1025-1035.
Crossref
Crossref
YOUNG MI KIM, ZHIKUN MA, SEUNGJIK LEE, JIYUN LEE, SHIBO LI & XIAOHE YANG. (2011) Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice. Oncology Letters 2:6, pages 1077-1081.
Crossref
Crossref
Elizabeth S. Yeh, Thomas W. Yang, Jason J. Jung, Heather P. Gardner, Robert D. Cardiff & Lewis A. Chodosh. (2011) Hunk is required for HER2/neu-induced mammary tumorigenesis. Journal of Clinical Investigation 121:3, pages 866-879.
Crossref
Crossref
Sarah M. Francis, Subrata Chakrabarti & Frederick A. Dick. (2011) A Context-Specific Role for Retinoblastoma Protein-Dependent Negative Growth Control in Suppressing Mammary Tumorigenesis. PLoS ONE 6:2, pages e16434.
Crossref
Crossref
Patricia A. J. Muller, Karen H. Vousden & Jim C. Norman. (2011) p53 and its mutants in tumor cell migration and invasion. Journal of Cell Biology 192:2, pages 209-218.
Crossref
Crossref
Stephen D. Hursting, Laura M. Lashinger, Powel H. Brown & Susan N. Perkins. 2011. Tumor Models in Cancer Research. Tumor Models in Cancer Research
423
443
.
Padmamalini Kannan-Thulasiraman, Darcie D. Seachrist, Ganapati H. Mahabeleshwar, Mukesh K. Jain & Noa Noy. (2010) Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth. Journal of Biological Chemistry 285:25, pages 19106-19115.
Crossref
Crossref
Ik Soo Kim & Sung Hee Baek. (2010) Mouse models for breast cancer metastasis. Biochemical and Biophysical Research Communications 394:3, pages 443-447.
Crossref
Crossref
Ayeda Ayed & Theodore HuppDadi Jiang & Laura D. Attardi. 2010. p53. p53
19
35
.
Lawrence A. Donehower & Guillermina Lozano. (2009) 20 years studying p53 functions in genetically engineered mice. Nature Reviews Cancer 9:11, pages 831-841.
Crossref
Crossref
Richard Marcotte & William J. Muller. (2008) Signal Transduction in Transgenic Mouse Models of Human Breast Cancer—Implications for Human Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 13:3, pages 323-335.
Crossref
Crossref
E L Milliken, K L Lozada, E Johnson, M D Landis, D D Seachrist, I Whitten, A L M Sutton, F W Abdul-Karim & R A Keri. (2007) Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Oncogene 27:12, pages 1759-1766.
Crossref
Crossref
Vassiliki Karantza‐Wadsworth & Eileen White. 2008. Programmed Cell Death, The Biology and Therapeutic Implications of Cell Death, Part B. Programmed Cell Death, The Biology and Therapeutic Implications of Cell Death, Part B
61
76
.
M M Moasser. (2007) The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 26:45, pages 6469-6487.
Crossref
Crossref
Erika M. Wall, Katy Milne, Michele L. Martin, Peter H. Watson, Patty Theiss & Brad H. Nelson. (2007) Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells. Cancer Research 67:13, pages 6442-6450.
Crossref
Crossref
Vassiliki Karantza-Wadsworth, Shyam Patel, Olga Kravchuk, Guanghua Chen, Robin Mathew, Shengkan Jin & Eileen White. (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes & Development 21:13, pages 1621-1635.
Crossref
Crossref
Josie Ursini-Siegel, Babette Schade, Robert D. Cardiff & William J. Muller. (2007) Insights from transgenic mouse models of ERBB2-induced breast cancer. Nature Reviews Cancer 7:5, pages 389-397.
Crossref
Crossref
Lawrence A. Donehower, Dora Bocangel, Melissa Dumble & Guillermina Lozano. 2007. 25 Years of p53 Research. 25 Years of p53 Research
183
207
.
A J Jackson-Fisher, G Bellinger, E Shum, J K Duong, A S Perkins, M Gassmann, W Muller, K C Kent Lloyd & D F Stern. (2006) Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. Oncogene 25:41, pages 5664-5672.
Crossref
Crossref
P.D. Ottewell, R.E. Coleman & I. Holen. (2005) From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Research and Treatment 96:2, pages 101-113.
Crossref
Crossref
J. Graeme Hodgson, Tiffany Malek, Sophia Bornstein, Sujatmi Hariono, David G. Ginzinger, William J. Muller & Joe W. Gray. (2005) Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling. Cancer Research 65:21, pages 9695-9704.
Crossref
Crossref
Aeree Kim, Bolin Liu, Dalia Ordonez-Ercan, Kathy M Alvarez, Lynn D Jones, Christine McKimmey, Susan M Edgerton, XiaoHe Yang & Ann D Thor. (2005) Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Breast Cancer Research 7:5.
Crossref
Crossref
Melissa D Landis, Darcie D Seachrist, Marjorie E Montañez-Wiscovich, David Danielpour & Ruth A Keri. (2005) Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic mice. Oncogene 24:33, pages 5173-5190.
Crossref
Crossref
Richard J. Gilbertson. (2005) ERBB2 in Pediatric Cancer: Innocent Until Proven Guilty. The Oncologist 10:7, pages 508-517.
Crossref
Crossref
Qiang Shen & Powel H. Brown. (2005) Transgenic mouse models for the prevention of breast cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 576:1-2, pages 93-110.
Crossref
Crossref
Laura D. Attardi & Lawrence A. Donehower. (2005) Probing p53 biological functions through the use of genetically engineered mouse models. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 576:1-2, pages 4-21.
Crossref
Crossref
Richard J�ger, Nicolaus Friedrichs, Inge Heim, Reinhard B�ttner & Hubert Schorle. (2005) Dual role of AP-2? in ErbB-2-induced mammary tumorigenesis. Breast Cancer Research and Treatment 90:3, pages 273-280.
Crossref
Crossref
Katrina Podsypanina, Yi Li & Harold E Varmus. (2004) Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. BMC Medicine 2:1.
Crossref
Crossref
Dalit Barkan, Cristina Montagna, Thomas Ried & Jeffrey E. Green. 2004. Mouse Models of Human Cancer. Mouse Models of Human Cancer.
Ala-Eddin Al Moustafa, William D Foulkes, Naciba Benlimame, Annick Wong, Lily Yen, Josée Bergeron, Gerald Batist, Lesley Alpert & Moulay A Alaoui-Jamali. (2004) E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 23:2, pages 350-358.
Crossref
Crossref
Christopher Calabrese, Adrian Frank, Kirsteen Maclean & Richard Gilbertson. (2003) Medulloblastoma Sensitivity to 17-Allylamino-17-demethoxygeldanamycin Requires MEK/ERK. Journal of Biological Chemistry 278:27, pages 24951-24959.
Crossref
Crossref
Gouri Chatterjee, Andrea Rosner, Yi Han, Edward T. Zelazny, Baolin Li, Robert D. Cardiff & Archibald S. Perkins. (2002) Acceleration of Mouse Mammary Tumor Virus-Induced Murine Mammary Tumorigenesis by a p53172H Transgene. The American Journal of Pathology 161:6, pages 2241-2253.
Crossref
Crossref
Anneke C Blackburn & D Joseph Jerry. (2002) Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?. Breast Cancer Research 4:3.
Crossref
Crossref
Tomasz Skorski. (2002) Oncogenic tyrosine kinases and the dna-damage response. Nature Reviews Cancer 2:5, pages 351-360.
Crossref
Crossref
G C Huang, S Hobbs, M Walton & R J Epstein. (2002) Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells. British Journal of Cancer 86:7, pages 1104-1109.
Crossref
Crossref
Chu-Xia Deng & Steven G Brodie. (2001) Knockout mouse models and mammary tumorigenesis. Seminars in Cancer Biology 11:5, pages 387-394.
Crossref
Crossref
Ralf Brandt, Agnes M-L Wong & Nancy E Hynes. (2001) Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents. Oncogene 20:39, pages 5459-5465.
Crossref
Crossref
Edward Zelazny, Baolin Li, Anne-Marie Anagnostopoulos, Allen Coleman & Archibald S. Perkins. (2001) Cooperating Oncogenic Events in Murine Mammary Tumorigenesis: Assessment of ErbB2, Mutant p53, and Mouse Mammary Tumor Virus. Experimental and Molecular Pathology 70:3, pages 183-193.
Crossref
Crossref
Pierre Rudolph, Per Alm, Håkan Olsson, Hans-Juergen Heidebrecht, Mårten Fernö, Bo Baldetorp & Reza Parwaresch. (2001) Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer. Human Pathology 32:3, pages 311-319.
Crossref
Crossref
Pamela E. Blackshear. (2016) Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview. Toxicologic Pathology 29:1, pages 105-116.
Crossref
Crossref
Kristen L. Murphey & Jeffrey M. Rosen. 2001. Hormonal Carcinogenesis III. Hormonal Carcinogenesis III
189
197
.
John N Hutchinson & William J Muller. (2000) Transgenic mouse models of human breast cancer. Oncogene 19:53, pages 6130-6137.
Crossref
Crossref
Kristen L. Murphy, Andrew P. Dennis & Jeffrey M. Rosen. (2000)
A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53‐null mammary epithelial cell mode
.
. The FASEB Journal 14:14, pages 2291-2302.
Crossref
Crossref
Cindy Go, Wei He, Ling Zhong, Ping Li, Juan Huang, Bill R Brinkley & Xiao-Jing Wang. (2000) Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRII. Oncogene 19:32, pages 3623-3631.
Crossref
Crossref
David F Stern. (2000) Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. Breast Cancer Research 2:3.
Crossref
Crossref
Peter M. Siegel, William R. Hardy & William J. Muller. (2000) Mammary gland neoplasia: insights from transgenic mouse models. BioEssays 22:6, pages 554-563.
Crossref
Crossref
Robert D Cardiff, Miriam R Anver, Barry A Gusterson, Lothar Hennighausen, Roy A Jensen, Maria J Merino, Sabine Rehm, Jose Russo, Fattaneh A Tavassoli, Lalage M Wakefield, Jerrold M Ward & Jeffrey E Green. (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:8, pages 968-988.
Crossref
Crossref
Kristen L Murphy & Jeffrey M Rosen. (2000) Mutant p53 and genomic instability in a transgenic mouse model of breast cancer. Oncogene 19:8, pages 1045-1051.
Crossref
Crossref
D J Jerry, F S Kittrell, C Kuperwasser, R Laucirica, E S Dickinson, P J Bonilla, J S Butel & D Medina. (2000) A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 19:8, pages 1052-1058.
Crossref
Crossref
Darryl L Hadsell, Kristen L Murphy, Sharon G Bonnette, Naomi Reece, Rodolfo Laucirica & Jeffrey M Rosen. (2000) Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis. Oncogene 19:7, pages 889-898.
Crossref
Crossref
John BarrettCarlo Gambacorti-Passerini. 2000. Allogeneic Immunotherapy for Malignant Diseases. Allogeneic Immunotherapy for Malignant Diseases.
Henk-Jan van Slooten, Marc J. van de Vijver, Anne-Lise B�rresen, Jorunn E. Eyfj�rd, Rut Valgardsd�ttir, Siegfried Scherneck, Jahn M. Nesland, Peter Devilee, Cees J. Cornelisse & Jan Hein van Dierendonck. (1999) Mutations in exons 5-8 of thep53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma. The Journal of Pathology 189:4, pages 504-513.
Crossref
Crossref
Harold Kim & William J. Muller. (1999) The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis. Experimental Cell Research 253:1, pages 78-87.
Crossref
Crossref
Jeffrey M. RosenShannon L. WyszomierskiDarryl Hadsell. (1999) REGULATION OF MILK PROTEIN GENE EXPRESSION. Annual Review of Nutrition 19:1, pages 407-436.
Crossref
Crossref
Frank E Jones & David F Stern. (1999) Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene 18:23, pages 3481-3490.
Crossref
Crossref
Priscilla A. Furth. 1999. Breast Cancer. Breast Cancer
171
180
.
Zhen Fan & John Mendelsohn. 1999. Breast Cancer. Breast Cancer
419
436
.